{
    "title": "US FDA advisers to discuss Pfizer's maternal RSV vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12098367/US-FDA-advisers-discuss-Pfizers-maternal-RSV-vaccine.html",
    "date": "2023-05-18",
    "keywords": [
        "rsv",
        "vaccine",
        "shot",
        "safety",
        "fda",
        "raghav",
        "mahobe",
        "sunny",
        "drug",
        "virus",
        "age",
        "infection",
        "trial",
        "immunity",
        "month",
        "approval",
        "food",
        "administration",
        "thursday",
        "respiratory",
        "vote",
        "panel",
        "effectiveness",
        "risk",
        "illness",
        "government",
        "staff",
        "tuesday",
        "number",
        "pfizer",
        "placebo",
        "difference",
        "chance",
        "latestage",
        "half",
        "pregnancy",
        "barney",
        "graham",
        "adviser",
        "health",
        "equity",
        "morehouse",
        "school",
        "medicine",
        "past",
        "level",
        "group",
        "development",
        "pace",
        "structure",
        "type",
        "protein",
        "surface",
        "form",
        "bodys",
        "response",
        "sanofi",
        "antibody",
        "nirsevimab",
        "commission",
        "february",
        "year",
        "disease",
        "control",
        "prevention",
        "use",
        "mariam",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}